tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ventyx Biosciences price target raised to $14 from $9 at Oppenheimer
PremiumThe FlyVentyx Biosciences price target raised to $14 from $9 at Oppenheimer
13d ago
Promising Phase II Trial Results of VTX3232 Bolster Buy Rating for Ventyx Biosciences
Premium
Ratings
Promising Phase II Trial Results of VTX3232 Bolster Buy Rating for Ventyx Biosciences
16d ago
Midday Fly By: Tesla reports mixed Q3, Trump in talks for quantum stakes
Premium
The Fly
Midday Fly By: Tesla reports mixed Q3, Trump in talks for quantum stakes
17d ago
Ventyx Biosciences announces results from VTX3232 study
PremiumThe FlyVentyx Biosciences announces results from VTX3232 study
17d ago
Ventyx Biosciences Announces Positive Phase 2 Trial Results
Premium
Company Announcements
Ventyx Biosciences Announces Positive Phase 2 Trial Results
17d ago
Ventyx Biosciences initiated with a Buy at Clear Street
Premium
The Fly
Ventyx Biosciences initiated with a Buy at Clear Street
1M ago
Positive Outlook on Ventyx Biosciences Due to Promising Developments in Neuro-Inflammatory Treatments
PremiumRatingsPositive Outlook on Ventyx Biosciences Due to Promising Developments in Neuro-Inflammatory Treatments
5M ago
Positive Buy Rating for Ventyx Biosciences Driven by Promising Phase 2a Trial Results and Strong Financial Position
Premium
Ratings
Positive Buy Rating for Ventyx Biosciences Driven by Promising Phase 2a Trial Results and Strong Financial Position
5M ago
Ventyx Biosciences Announces Positive Phase 2a Trial Results
Premium
Company Announcements
Ventyx Biosciences Announces Positive Phase 2a Trial Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100